These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25851154)

  • 1. Authors' reply to Wardlaw and Berge.
    Alper BS; Malone-Moses M; McLellan JS; Prasad K; Manheimer E
    BMJ; 2015 Apr; 350():h1795. PubMed ID: 25851154
    [No Abstract]   [Full Text] [Related]  

  • 2. Cochrane reviewers' response to Alper and colleagues' analysis of thrombolysis in acute ischaemic stroke.
    Wardlaw J; Berge E
    BMJ; 2015 Apr; 350():h1790. PubMed ID: 25850827
    [No Abstract]   [Full Text] [Related]  

  • 3. With a Little Help From My Friends: Seeking Consistent and Persuasive Evidence.
    Haley EC
    Stroke; 2017 Aug; 48(8):2326-2328. PubMed ID: 28626047
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolysis in acute ischaemic stroke: time for a rethink?
    Alper BS; Malone-Moses M; McLellan JS; Prasad K; Manheimer E
    BMJ; 2015 Mar; 350():h1075. PubMed ID: 25786912
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based emergency medicine: updates, feedback, and links.
    Wyer PC; Cordell WH
    Ann Emerg Med; 1999 Nov; 34(5):657-63. PubMed ID: 10533014
    [No Abstract]   [Full Text] [Related]  

  • 6. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM; Sandercock PA; Murray V
    BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic therapy for acute ischemic stroke].
    Mori E
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():33-7. PubMed ID: 17469531
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of lack of improvement after thrombolytic stroke therapy.
    Pastewski A; Kupfer Y; Tessler S
    JAMA; 2005 Jan; 293(4):421; author reply 421. PubMed ID: 15671423
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 11. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute stroke treatment: thrombolysis.
    Bogousslavsky J; Paciaroni M; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():14-6. PubMed ID: 11070393
    [No Abstract]   [Full Text] [Related]  

  • 15. Litigation regarding tPA and stroke.
    Pilcher CA
    Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
    [No Abstract]   [Full Text] [Related]  

  • 16. Soduko.
    Hughes T
    Pract Neurol; 2011 Dec; 11(6):375. PubMed ID: 22100953
    [No Abstract]   [Full Text] [Related]  

  • 17. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Liao X; Wang Y; Wang Y
    Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
    [No Abstract]   [Full Text] [Related]  

  • 19. 4.5 hours: the new time window for tissue plasminogen activator in stroke.
    Davis SM; Donnan GA
    Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous thrombolytic therapy for acute ischemic stroke in Tuzla Canton, Bosnia and Herzegovina.
    Smajlović D; Salihović D; Avdić L; Dostović Z; Ibrahimagić OĆ; Vidović M
    Int J Stroke; 2013 Oct; 8(7):E48. PubMed ID: 24024924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.